Med platforms Matter: Emerging strategies for RNA therapeutics

About this video

With the continued rise of interdisciplinary approaches bridging life and physical sciences, researchers are using every toolkit available to tackle the most pressing health problems. Med and Matter recognize that not only are emerging in medical technologies being developed on innovative and advanced materials platforms, but biological materials themselves can be designed similarly to synthetic materials systems.

Simply put, the underlying materials used for medicine matter. Recently, RNA has entered the forefront of emerging therapeutics, requiring new fundamental approaches to predictive modeling and design of RNA, RNA delivery platforms, and clinical use. Join us to hear about the latest advances from our excellent panel!

About the presenters

Ryan Flynn

Dr. Ryan Flynn is an assistant professor at Boston Children’s Hospital in the Stem Cell Program and the department of Stem Cell and Regenerative Biology at Harvard University, where his lab is investigating the chemical nature and biological role of RNA glycosylation.

Dr. Flynn has won multiple awards including the Burroughs Wellcome Fund, the Sontag Foundation, and the Rita Allen Foundation Scholars Award.

Laura Sepp-Lorenzino

Laura Sepp-Lorenzino, PhD joined Intellia Therapeutics in 2019 as chief scientific officer and is responsible for research and early development. Intellia’s leading CRISPR platform supports a full-spectrum therapeutic strategy. Laura previously held leadership positions at Vertex, Alnylam, and Merck.

Giovanni Traverso

Giovanni Traverso is an assistant professor in the department of mechanical engineering at the Massachusetts Institute of Technology (MIT) and also a gastroenterologist with Brigham and Women’s Hospital (BWH), Harvard Medical School. His current research program is focused on developing the next generation of drug delivery systems to enable safe and efficient delivery of therapeutics, working on a biomedical device to support new modes of drug administration, and sensing a broad array of physiologic and pathophysiologic signals.

Comments

Cell Press (34)
0/34
Next up
How To Publish in High Impact Journals
Ethics and Copyright: Insights for Research Publishing from Cell Press
Best Practices in Submitting Research for Highly Selective Journals
Essential tips for publishing in high-impact journals
Innovation at Cell Press: Make the most of free Cell Press resources
Must Know Tips for Publishing in Premium Journals
Learn From The Editors: Tips For Impactful Submissions
Learn from the Editors: Authoring in High-Impact Journals
How to Prepare Your Manuscripts for Publication in Top Journals
Techniques for Publishing in Transformative Ground-Breaking Journals
Strengthening Research Capabilities Remotely
How to publish in groundbreaking journals
Navigating the Publishing Process for Groundbreaking Journals
The Future of Batteries
Designing Quantum Materials using AI & Machine Learning: Opportunities for Collaboration
Understanding Materials for Quantum Information Processing
Essential Tips for Publishing in High Impact Journals
Navigating the Publishing Process for High Impact Journals
How to Prepare Your manuscripts for Publication in Top Journals
New Trends and Future Directions in Catalysis
Light/Matter Interactions: Illuminating Materials and Researchers
Introducing the Editor-in-Chief of Chem Catalysis
Med platforms Matter: Materials science for cancer diagnostics and treatment
Accessible high-throughput experimentation from startup to scale
Implementing flow chemistry in multidisciplinary synthesis and catalysis
2021 Pieces of Matter: Perovskites
Authoring tips, Inclusion & Diversity in Scientific Publishing
New approaches and strategies in main group catalysis
Publishing in Chem from Cell Press
Bioengineering for renewable energy and a sustainable future
Synergistic Catalysis
Catalysis for Clean Energy
Med platforms Matter: Emerging strategies for RNA therapeutics
Understanding the chemical mediators of ecological interactions